首页> 外文期刊>American Journal of Obstetrics and Gynecology >Prolapse recurrence following sacrocolpopexy vs uterosacral ligament suspension: a comparison stratified by Pelvic Organ Prolapse Quantification stage
【24h】

Prolapse recurrence following sacrocolpopexy vs uterosacral ligament suspension: a comparison stratified by Pelvic Organ Prolapse Quantification stage

机译:脱垂后的恶作剧血糖悬浮液后复发:通过盆腔器官脱垂量化阶段分层分层的比较

获取原文
           

摘要

Background Insufficient evidence evaluates which pelvic organ prolapse surgery is best suited to an individual woman based on the stage of her prolapse. Objective We sought to compare prolapse recurrence rates following sacrocolpopexy and uterosacral ligament suspension after stratifying by preoperative Pelvic Organ Prolapse Quantification stage. Study Design We compared all women who underwent minimally invasive sacrocolpopexy or vaginal or minimally invasive uterosacral ligament suspension from 2009 through 2015 at a large academic center. All women with preoperative and postoperative Pelvic Organ Prolapse Quantification data were included. Patients were grouped by preoperative Pelvic Organ Prolapse Quantification stage for analysis. Recurrence rates following sacrocolpopexy and uterosacral ligament suspension were compared for patients presenting with stage II, III, and IV prolapse, adjusting for potential confounders in regression models. Prolapse recurrence was defined as any retreatment for prolapse or any Pelvic Organ Prolapse Quantification point beyond the hymen. Results Of 756 women, 633 underwent sacrocolpopexy (83.7%) and 123 (16.3%) underwent uterosacral ligament suspension. In all, 189 (25%) had preoperative Pelvic Organ Prolapse Quantification stage II prolapse, 527 (69.7%) stage III, and 40 (5.3%) stage IV. Patients were predominantly Caucasian (97.3%) with mean age 59.8 ?.5 years. Compared to uterosacral ligament suspension patients, more sacrocolpopexy patients had undergone prior prolapse repair (20.9% vs 5.7%, P 齈 034). Characteristics of the groups were otherwise similar. Median follow-up was 41.0 (interquartile range 13.0-88.8) weeks. Stage II prolapse patients had similar recurrence rates following sacrocolpopexy or uterosacral ligament suspension (6.0% vs 5.0, P ?1.00). However, stage III prolapse patients were more likely to experience recurrence following uterosacral ligament suspension (25.7% vs 7.8%, P Conclusion Sacrocolpopexy resulted in a lower prolapse recurrence rate than uterosacral ligament suspension for stage III prolapse. However, there was no difference in recurrence rate among women with preoperative stage II prolapse, suggesting mesh augmentation may not be indicated for these patients. Larger prospective trials are necessary for confirmation.
机译:背景技术证据不足,评估哪种骨盆器官脱垂手术最适合基于她脱垂阶段的个体妇女。目的我们试图在术前盆腔器官脱垂定量阶段分层后,比较骶骨肝癌和子宫韧带悬浮液后的脱垂复发率。研究设计我们将所有侵入性侵袭性的侵袭性的侵袭性或阴道或微创子宫颈韧带悬浮液的所有女性与2015年的大型学术中心相比。所有患有术前和术后盆腔器官脱垂量化数据的妇女都是包括在内的。通过术前盆腔器官脱垂定量阶段进行分析患者进行分析。比较了患有阶段II,III和IV脱垂的患者的患者后患者进行的复发率和子宫韧带悬浮液,调整回归模型中的潜在混凝剂。脱垂复发被定义为脱垂的任何撤退或任何盆腔器官脱垂量,超出处女膜。结果756名妇女,633例,造成的骶骨(83.7%)和123(16.3%)接受子宫韧带悬浮液。总体而言,189名(25%)具有术前盆腔器官脱垂定量阶段II脱垂,527(69.7%)第III期,40(5.3%)第四阶段。患者主要是白种人(97.3%),平均为59.8岁。5年。与子宫韧带悬浮患者相比,更多的恶助的患者经过早期脱垂修复(20.9%Vs 5.7%,P齈034)。否则相似的组特征。中位后续时间为41.0(四分位数13.0-88.8)周。阶段二期脱垂患者在骶骨或子宫韧带悬浮液后具有相似的复发率(6.0%Vs 5.0,P?1.00)。然而,在子宫韧带悬浮液(25.7%Vs 7.8%的25.7%Vs 7.8%,P结果中,阶段III脱垂患者更容易发发复发,导致脱垂复发率低于子宫韧带悬浮液,但复发没有差异术前阶段II脱垂的女性的速率,可能不会针对这些患者表明网格增强。确认需要更大的前瞻性试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号